Literature DB >> 21110996

Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers.

Michael E Ballard1, Harriet de Wit.   

Abstract

RATIONALE: Previous studies examining the combined effects of ethanol and cannabis, or its primary psychoactive ingredient, ∆⁹-tetrahydrocannabinol (THC), have provided mixed results. Data from an in vitro study suggests that combined, sub-threshold doses of these drugs may interact to produce synergistic effects. Very low doses of the two drugs in combination have not been tested in humans.
MATERIALS AND METHODS: This study assessed whether combinations of acute, very low doses of ethanol and THC produce synergistic effects on subjective, cognitive, and physiological measures. Healthy volunteers (n=11) received capsules containing placebo or THC (2.5 mg), and beverages containing placebo or ethanol (0.1 and 0.2 g/kg) alone, and in combination, across separate sessions, in a within-subjects, randomized, double-blind design. During each session, participants completed measures of working memory, psychomotor ability, and simple reaction time, and provided subjective mood and drug effect ratings. Cardiovascular measures were obtained at regular intervals.
RESULTS: As intended, when administered alone, these very low doses of ethanol and THC had only moderate effects on isolated measures. The combined effects of these drugs were not synergistic, and in some cases appeared to be less-than-additive.
CONCLUSIONS: Our data provide no evidence for synergistic effects of acute combinations of very-low-dose ethanol and THC on subjective or physiologic response, or on cognitive performance.
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110996      PMCID: PMC3018238          DOI: 10.1016/j.pbb.2010.11.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  42 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Acute marijuana effects on human risk taking.

Authors:  Scott D Lane; Don R Cherek; Oleg V Tcheremissine; Lori M Lieving; Cythia J Pietras
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

3.  Marijuana, alcohol and actual driving performance.

Authors:  J. G. Ramaekers; H. W. J. Robbe; J. F. O'Hanlon
Journal:  Hum Psychopharmacol       Date:  2000-10       Impact factor: 1.672

4.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area.

Authors:  D N Linsenbardt; S L Boehm
Journal:  Neuroscience       Date:  2009-08-07       Impact factor: 3.590

6.  Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving.

Authors:  Anthony Liguori; Catherine P Gatto; David B Jarrett
Journal:  Psychopharmacology (Berl)       Date:  2002-06-05       Impact factor: 4.530

7.  Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance.

Authors:  L D Chait; J L Perry
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

8.  Ethanol and delta9-tetrahydrocannabinol interactive effects on human perceptual, cognitive and motor functions. II.

Authors:  G B Chesher; H M Franks; D M Jackson; G A Starmer; R K Teo
Journal:  Med J Aust       Date:  1977-04-02       Impact factor: 7.738

9.  Interaction between marihuana and ethanol: effects on psychomotor performance.

Authors:  M Perez-Reyes; R E Hicks; J Bumberry; A R Jeffcoat; C E Cook
Journal:  Alcohol Clin Exp Res       Date:  1988-04       Impact factor: 3.455

10.  Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane.

Authors:  B S Basavarajappa; T B Cooper; B L Hungund
Journal:  Brain Res       Date:  1998-05-18       Impact factor: 3.252

View more
  21 in total

1.  Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey.

Authors:  Meenakshi S Subbaraman; William C Kerr
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

2.  Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders.

Authors:  Jane Metrik; Rachel L Gunn; Kristina M Jackson; Alexander W Sokolovsky; Brian Borsari
Journal:  Alcohol Clin Exp Res       Date:  2018-05-08       Impact factor: 3.455

Review 3.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 4.  Can cannabis be considered a substitute medication for alcohol?

Authors:  Meenakshi Sabina Subbaraman
Journal:  Alcohol Alcohol       Date:  2014-01-08       Impact factor: 2.826

Review 5.  Role of cannabis in cardiovascular disorders.

Authors:  Hemant Goyal; Hamza H Awad; Jalal K Ghali
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Ecological momentary assessment of working memory under conditions of simultaneous marijuana and tobacco use.

Authors:  Randi Melissa Schuster; Robin J Mermelstein; Donald Hedeker
Journal:  Addiction       Date:  2016-03-08       Impact factor: 6.526

Review 7.  Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence.

Authors:  Hollis C Karoly; J Megan Ross; Jarrod M Ellingson; Sarah W Feldstein Ewing
Journal:  J Dual Diagn       Date:  2019-09-13

8.  Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.

Authors:  Meenakshi Sabina Subbaraman; Jane Metrik; Deidre Patterson; Robert Swift
Journal:  Addiction       Date:  2017-01-10       Impact factor: 6.526

9.  Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests.

Authors:  Luke A Downey; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Martin Boorman; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2012-07-05       Impact factor: 4.530

10.  Cognitive Functioning Related to Binge Alcohol and Cannabis Co-Use in Abstinent Adolescents and Young Adults.

Authors:  Natasha E Wade; Kara S Bagot; Susan F Tapert; Staci A Gruber; Francesca M Filbey; Krista M Lisdahl
Journal:  J Stud Alcohol Drugs       Date:  2020-07       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.